American Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57.1M Buy
663,049
+176,837
+36% +$15.9M 3.07% 10
2025
Q4
$42.5M Sell
486,212
-12,847
-3% -$975K 1.87% 24
2025
Q3
$28.6M Buy
499,059
+15,537
+3% +$895K 1.14% 28
2025
Q2
$28.5M Buy
483,522
+188,681
+64% +$12.2M 1.18% 31
2025
Q1
$21.6M Buy
294,841
+261,731
+790% +$21.6M 0.88% 37
2024
Q4
$2.74M Buy
+33,110
New +$2.61M 0.1% 49

Other funds holding GMED

American Capital Management's GMED Position: Q1 2026 in Review

American Capital Management increased its Globus Medical (GMED) stake by 36% in Q1 2026, buying an estimated $15.9M and bringing the position to 663,049 shares worth $57.1M. The position accounts for 3.07% of the portfolio, ranked #10.

American Capital Management first reported a position in GMED in Q4 2024 and has held it in 6 quarters since. 605 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • American Capital Management held 663,049 shares of Globus Medical worth $57.1M as of Q1 2026.
  • American Capital Management bought 176,837 Globus Medical shares in Q1 2026, an estimated $15.9M.
  • Globus Medical made up 3.07% of American Capital Management's portfolio in Q1 2026, its #10 holding.
  • American Capital Management first reported a position in Globus Medical in Q4 2024 and has held it in 6 quarters since.
  • 605 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on American Capital Management's 13F filing for Q1 2026, filed 15 May 2026.